Acute on Chronic Liver Failure
H2Stem is Promethera’s follow-on hepato-biliary stem cell product currently in pre-clinical development with different features compared to HepaStem.
Heparesc is Promethera's cell technology comprised of liver-derived mature hepatocytes (HHLivC). Heparesc allows for the treatment of several patients with one donated liver.
HepaStem is Promethera's cell therapy product comprised of Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC). It displays multiple modes of action including anti-inflammatory, anti-fibrotic effects and immunomodulation.
Heterologous Human Adult Liver-derived Progenitor Cells
Heterologous Human Liver Cells
The tech transfer office of UCL
Urea Cycle Disorders
Université Catholique de Louvain
Université Libre de Bruxelles